ICD-10-PCS › 3
ICD-10-PCS codes starting with 3
1,516 codes, page 11 of 16. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| 3E0H7HZ | Introduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H7KZ | Introduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H7SF | Introduction of Other Gas into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H7TZ | Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening | Valid |
| 3E0H804 | Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H805 | Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H80M | Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H828 | Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H829 | Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H83Z | Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H86Z | Introduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H87Z | Introduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H8BZ | Introduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H8GC | Introduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H8HZ | Introduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H8KZ | Introduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H8SF | Introduction of Other Gas into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0H8TZ | Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J304 | Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J305 | Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J30M | Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J328 | Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J329 | Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J33Z | Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J36Z | Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J37Z | Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J3BZ | Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J3GC | Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J3HZ | Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J3KZ | Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J3SF | Introduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J3TZ | Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J3U0 | Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J3U1 | Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach | Valid |
| 3E0J4GC | Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Endoscopic Approach | Valid |
| 3E0J704 | Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J705 | Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J70M | Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J728 | Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J729 | Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J73Z | Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J76Z | Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J77Z | Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J7BZ | Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J7GC | Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J7HZ | Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J7KZ | Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J7SF | Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J7TZ | Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J7U0 | Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J7U1 | Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | Valid |
| 3E0J804 | Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J805 | Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J80M | Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J828 | Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J829 | Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J83Z | Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J86Z | Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J87Z | Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J8BZ | Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J8GC | Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J8HZ | Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J8KZ | Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J8SF | Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J8TZ | Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J8U0 | Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0J8U1 | Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K304 | Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K305 | Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K30M | Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K328 | Introduction of Oxazolidinones into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K329 | Introduction of Other Anti-infective into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K33Z | Introduction of Anti-inflammatory into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K36Z | Introduction of Nutritional Substance into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K37Z | Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K3BZ | Introduction of Anesthetic Agent into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K3GC | Introduction of Other Therapeutic Substance into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K3HZ | Introduction of Radioactive Substance into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K3KZ | Introduction of Other Diagnostic Substance into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K3SF | Introduction of Other Gas into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K3TZ | Introduction of Destructive Agent into Genitourinary Tract, Percutaneous Approach | Valid |
| 3E0K4GC | Introduction of Other Therapeutic Substance into Genitourinary Tract, Percutaneous Endoscopic Approach | Valid |
| 3E0K704 | Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K705 | Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K70M | Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K728 | Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K729 | Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K73Z | Introduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K76Z | Introduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K77Z | Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K7BZ | Introduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K7GC | Introduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K7HZ | Introduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K7KZ | Introduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening | Valid |